Recurrent Oncogenic JAK and STAT Alterations in Cutaneous CD30-Positive Lymphoproliferative Disorders-Reference-Cited by-同舟云学术

Recurrent Oncogenic JAK and STAT Alterations in Cutaneous CD30-Positive Lymphoproliferative Disorders

Published:2020-10 Issue:10 Volume:140 Page:2023-2031.e1
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Maurus Katja^ORCID,Appenzeller Silke^ORCID,Roth Sabine^ORCID,Brändlein Stephanie^ORCID,Kneitz Hermann^ORCID,Goebeler Matthias^ORCID,Rosenwald Andreas^ORCID,Geissinger Eva^ORCID,Wobser Marion^ORCID

Funder

Interdisciplinary Unit for Personalized Oncology

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference58 articles.

1. Applicability and prognostic value of the new TNM classification system in 135 patients with primary cutaneous anaplastic large cell lymphoma;Benner;Arch Dermatol,2009

2. JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma;Bouchekioua;Leukemia,2014

3. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data;Cerami;Cancer Discov,2012

4. An integrated data resource for genomic analysis of cutaneous T-cell lymphoma;Chang;J Invest Dermatol,2018

5. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor;Cools;Genes Chromosomes Cancer,2002

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fifth Edition of the World Health Organization Classification of Tumors of the Hematopoietic and Lymphoid Tissues: Mature T-Cell, NK-Cell, and Stroma-Derived Neoplasms of Lymphoid Tissues;Modern Pathology;2024-08

2. Diagnosis and management of cutaneous lymphomas and lymphoid proliferations in children, adolescents and young adults (CAYA);Best Practice & Research Clinical Haematology;2023-03

3. Janus Kinase-Signal Transducer and Activator of Transcription Inhibitors for the Treatment and Management of Cancer;Journal of Environmental Pathology, Toxicology and Oncology;2023

4. Genetics Abnormalities with Clinical Impact in Primary Cutaneous Lymphomas;Cancers;2022-10-11

5. A Case of Tofacitinib-Induced Lymphomatoid Papulosis With Ocular Involvement;The American Journal of Dermatopathology;2022-05-04